Publication: Maintenance ECT in Treatment-Resistant Schizophrenia
0
0
Issued Date
2000
Resource Type
File Type
application/pdf
ISSN
1252208
Other identifier(s)
2-s2.0-0034201252
Rights Holder(s)
มหาวิทยาลัยศรีนครินทรวิโรฒ
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol 83, No.6 (2000), p.657-662
Suggested Citation
Chanpattana W. Maintenance ECT in Treatment-Resistant Schizophrenia. Journal of the Medical Association of Thailand. Vol 83, No.6 (2000), p.657-662. Retrieved from: https://hdl.handle.net/20.500.14740/7027
Author(s)
Abstract
Although electroconvulsive therapy (ECT) has been used to treat schizophrenia since its inception in 1938, its efficacy as long-term treatment is still controversial. A 2-Phase, prospective study has been conducted in 21 patients with schizophrenia. The duration of study was 1 year. Bilateral ECT combined with flupenthixol (18-24 mg/day) was used throughout. Brief Psychiatric Rating Scale (BPRS), Global Assessment of Functioning (GAF), and Mini-Mental-State Exam (MMSE) were used to measure the outcome. No patients suffered relapses. There were marked reductions in BPRS scores (73 per cent and 70 per cent), and increases in GAF scores (68 per cent and 91 per cent), at the end of Phases I and II, respectively. This study suggests a long-term efficacy of ECT combined with neuroleptic therapy in patients with schizophrenia.
Subject(s)
Flupentixol
Neuroleptic agent
Adolescent
Adult
Article
Brief Psychiatric Rating Scale
Clinical trial
Drug resistance
Electroconvulsive therapy
Female
Human
Long term care
Male
Methodology
Multimodality cancer therapy
Phase 1 clinical trial
Phase 2 clinical trial
Prognosis
Prospective study
Schizophrenia
Treatment failure
Treatment outcome
Adolescent
Adult
Antipsychotic Agents
Brief Psychiatric Rating Scale
Combined Modality Therapy
Drug Resistance
Electroconvulsive Therapy
Female
Flupenthixol
Humans
Long-Term Care
Male
Prognosis
Prospective Studies
Schizophrenia
Treatment Failure
Treatment Outcome
Neuroleptic agent
Adolescent
Adult
Article
Brief Psychiatric Rating Scale
Clinical trial
Drug resistance
Electroconvulsive therapy
Female
Human
Long term care
Male
Methodology
Multimodality cancer therapy
Phase 1 clinical trial
Phase 2 clinical trial
Prognosis
Prospective study
Schizophrenia
Treatment failure
Treatment outcome
Adolescent
Adult
Antipsychotic Agents
Brief Psychiatric Rating Scale
Combined Modality Therapy
Drug Resistance
Electroconvulsive Therapy
Female
Flupenthixol
Humans
Long-Term Care
Male
Prognosis
Prospective Studies
Schizophrenia
Treatment Failure
Treatment Outcome
